Table of Contents

company-logo

Pyxis Oncology, Inc., a preclinical stage biopharmaceutical company, engages in the development of therapies to treat cancers. Its immune-oncology product candidates include PYX-106, an investigational fully human immunoglobulin G1 isotype siglec-15 targeting antibody for the treatment of thyroid cancer, head and neck squamous cell carcinoma, non-small cell lung cancer (NSCLC), and other solid tumors; and PYX-102, an investigational immune-therapeutic for treatment of solid tumors. The company's antibody drug conjugate (ADC) product candidates comprise of PYX-201, an investigational novel ADC to treat NSCLC, breast cancer, and other solid tumors; PYX-202, an investigational novel ADC for treatment of SCLC, soft tissue sarcoma, and other solid tumors; and PYX-203, an investigational ADC for the treatment of acute myeloid leukemia and myeloid dysplastic syndrome. The company was incorporated in 2018 and is headquartered in Cambridge, Massachusetts.

Pyxis Oncology Dividend Announcement

• Pyxis Oncology does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Pyxis Oncology dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Pyxis Oncology Dividend History

Pyxis Oncology Dividend Yield

Pyxis Oncology current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Pyxis Oncology stock? Use our calculator to estimate your expected dividend yield:

Pyxis Oncology Financial Ratios

P/E ratio-4.84
PEG ratio0.39
P/B ratio1.69
ROE-38.34%
Payout ratio0.00%
Current ratio9.53
Quick ratio9.53
Cash Ratio1.57

Pyxis Oncology Dividend FAQ

Does Pyxis Oncology stock pay dividends?
Pyxis Oncology does not currently pay dividends to its shareholders.
Has Pyxis Oncology ever paid a dividend?
No, Pyxis Oncology has no a history of paying dividends to its shareholders. Pyxis Oncology is not known for its dividend payments.
Why doesn't Pyxis Oncology pay dividends?
There are several potential reasons why Pyxis Oncology would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Pyxis Oncology ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Pyxis Oncology has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Pyxis Oncology a dividend aristocrat?
Pyxis Oncology is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Pyxis Oncology a dividend king?
Pyxis Oncology is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Pyxis Oncology a dividend stock?
No, Pyxis Oncology is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Pyxis Oncology stocks?
To buy Pyxis Oncology you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Pyxis Oncology stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.